We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Analysis & Separations

Stay up to date on the topics that matter to you

BioCentriq

BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months.

Latest BioCentriq Content

Product News

Autolomous and BioCentriq Partner To Speed Up Cell Therapy Delivery

Collaboration leverages cutting-edge digital platform to streamline development and manufacturing activities and speed patient access to life-changing treatments.

Never miss a story

with the Breaking Science News daily newsletter